Share Email Print

Proceedings Paper

Mid-IR super-continuum generation
Author(s): Mohammed N. Islam; Chenan Xia; Mike J. Freeman; Jeremiah Mauricio; Andy Zakel; Kevin Ke; Zhao Xu; Fred L. Terry Jr.
Format Member Price Non-Member Price
PDF $17.00 $21.00

Paper Abstract

A Mid-InfraRed FIber Laser (MIRFIL) has been developed that generates super-continuum covering the spectral range from 0.8 to 4.5 microns with a time-averaged power as high as 10.5W. The MIRFIL is an all-fiber integrated laser with no moving parts and no mode-locked lasers that uses commercial off-the-shelf parts and leverages the mature telecom/fiber optics platform. The MIRFIL power can be easily scaled by changing the repetition rate and modifying the erbium-doped fiber amplifier. Some of the applications using the super-continuum laser will be described in defense, homeland security and healthcare. For example, the MIRFIL is being applied to a catheter-based medical diagnostic system to detect vulnerable plaque, which is responsible for most heart attacks resulting from hardening-of-the-arteries or atherosclerosis. More generally, the MIRFIL can be a platform for selective ablation of lipids without damaging normal protein or smooth muscle tissue.

Paper Details

Date Published: 19 February 2009
PDF: 12 pages
Proc. SPIE 7195, Fiber Lasers VI: Technology, Systems, and Applications, 71950W (19 February 2009); doi: 10.1117/12.807206
Show Author Affiliations
Mohammed N. Islam, Univ. of Michigan (United States)
Omni Sciences Inc. (United States)
Chenan Xia, Univ. of Michigan (United States)
Mike J. Freeman, Omni Sciences Inc. (United States)
Jeremiah Mauricio, Omni Sciences Inc. (United States)
Andy Zakel, Omni Sciences Inc. (United States)
Kevin Ke, Univ. of Michigan (United States)
Zhao Xu, Univ. of Michigan (United States)
Fred L. Terry Jr., Univ. of Michigan (United States)

Published in SPIE Proceedings Vol. 7195:
Fiber Lasers VI: Technology, Systems, and Applications
Denis V. Gapontsev; Dahv A. Kliner; Jay W. Dawson; Kanishka Tankala, Editor(s)

© SPIE. Terms of Use
Back to Top
Sign in to read the full article
Create a free SPIE account to get access to
premium articles and original research
Forgot your username?